These pathways may be operating clinically as liver biopsies from patients with MASLD showed positive correlation of ChREBPβ with FASN, L-PK, PCK1, and G6PC [82]. This evidence concerns the gene G6PC1 and metabolic dysfunction-associated steatotic liver disease.